The role of SGOL1 in the prognosis of skin cutaneous melanoma (SKCM): SGOL1 在皮肤黑色素瘤(SKCM) 预后中的作用: 目的: 分析皮肤黑色素瘤(SKCM) 中SGOL1 的 …
L Xuankai, FU Shuying, C Hongda - 开元Medical-Research, 2022 - mrhk.cc
… age groups (“< 60 years old” and “≥ 60 years old”). After excluding the cases without Clark
grade or tumor stage … mechanism of SKCM and find new therapeutic targets. Shugoshin (Sgo…
grade or tumor stage … mechanism of SKCM and find new therapeutic targets. Shugoshin (Sgo…
[PDF][PDF] 熙ETTTEICIETEI: IIIII: I: ETET
D Stacey, J Davison - researchgate.net
… stage prostate cancer with a group of “surrogate patients"— men, without prostate cancer,
of the same age … of that development process are very similar to the two stages offield-testing …
of the same age … of that development process are very similar to the two stages offield-testing …
早期经尿道前列腺隧道式电切治疗前列腺癌近距离照射治疗术后尿潴留
Y Zhang, Z Zhang, Y Yu, Y Chen, K Ni, M Wang… - Journal of Zhejiang …, 2014 - Springer
… patients with localized prostate cancer of clinical stages T1c to … Gleason score was 7 (range
6 to 8) and mean serum prostate-… Patients’ mean age was 75.5 years (range 68 to 83 years) …
6 to 8) and mean serum prostate-… Patients’ mean age was 75.5 years (range 68 to 83 years) …
IS-S3-1 指_ G Advance in the treatment of IBD
K Matsuoka - jstage.jst.go.jp
… in hospitalization rate of 17.55% and APC for 0-19 age group … Recent development of
medications enabled better … at a significantly higher incidence in high score group. Conclusions: It …
medications enabled better … at a significantly higher incidence in high score group. Conclusions: It …
产学研用协作促进中国医学影像AI 产业健康发展
萧毅， 刘士远 - Chinese Medical Sciences Journal, 2019 - cmsj.cams.cn
… This article introduces the current status of collaboration, the … age interpretation, diagnosis
of brain white matter diseases, joint disease, prostate cancer, bladder cancer, colorectal cancer…
of brain white matter diseases, joint disease, prostate cancer, bladder cancer, colorectal cancer…
[HTML][HTML] CCL2(rs3760399)基因多态性和前列腺癌临床病理特征的相关性
潘剑， 韦煜， 叶定伟， 朱耀 - 2022 - jms.fudan.edu.cn
… features of prostate cancer, and to compare the variation frequency of CCL2 … score, clinical
M stage, and metastatic burden of prostate cancer, and to compare the variation frequency of …
M stage, and metastatic burden of prostate cancer, and to compare the variation frequency of …
CPCC 晚期前列腺癌中国专家共识——转移性激素敏感性前列腺癌起始应用新型内分泌治疗的全程管理(2022 年版)
…, H Jian, Chinese Prostate Cancer Consortium - 中国癌症 …, 2023 - china-oncology.com
… Estimated agestandardized incidence rates (World) in 2020, World, both sexes, all … -specific
antigen-based population screening for prostate cancer: current status in Japan and future …
antigen-based population screening for prostate cancer: current status in Japan and future …
[HTML][HTML] 75 岁以上癌症患者免疫治疗相关不良反应的回顾性分析
陆嘉宁， 马佩， 高雯， 束永前 - 南京医科大学学报(自然科学版), 2023 - jnmu.njmu.edu.cn
… There were 22 cases of grade 3 and above adverse events,accounting for 13.2% of the total
… Conclusion:Based on the data of the current study,the adverse events of immune checkpoint …
… Conclusion:Based on the data of the current study,the adverse events of immune checkpoint …
[HTML][HTML] 855 例前列腺癌患者错配修复基因胚系突变临床研究
方邦伟， 韦煜， 潘剑， 张挺维， 叶定伟… - Journal of Zhejiang …, 2023 - ncbi.nlm.nih.gov
… were identified in 855 prostate cancer patients, including 1 … had lower age of onset (P<0.05)
and initial prostate-specific … the two groups in Gleason score and TMN staging (both P>0.05). …
and initial prostate-specific … the two groups in Gleason score and TMN staging (both P>0.05). …